Events Partner Content 3rd International Conference on Pancreatic Cancer and Liver ... Making Life Better: Fight Against Pancreatic Cancer
News Merck and Pfizer’s immunotherapy combination gains Breakthro... Merck and Pfizer have received a major boost to their immune-oncology alliance with a second FDA Breakthrough Therapy Designation for Bavencio, this time in combination with Pfizer’s Inlyta
Partner Content Partner Content CAR:T - Has biology outpaced the ability to deliver? Experts comment on manufacturing of CAR-T
Events Partner Content CAR-T Congress USA | 20 - 22 March 2018 | Boston Targeting | Commercialization | Scalability
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
